UTSW researchers neutralize genetic risk factor found in 50 to 80 percent of human cases
UT Southwestern researchers have succeeded in neutralizing what they believe is a primary factor in late-onset Alzheimer’s disease, opening the door to development of a drug that could be administered before age 40, and taken for life, to potentially prevent the disease in 50 to 80 percent of at-risk adults.
Apolipoprotein E (ApoE) is a protein that carries fatty substances called lipids and cholesterol around the brain and plays an important role in repair mechanisms. There are three major forms of ApoE (i.e., ApoE2, ApoE3, and ApoE4); individuals who carry ApoE4 are up to 10 times more likely to develop Alzheimer’s than those with ApoE2 and ApoE3 forms. ApoE4 promotes accumulation of the b-amyloid protein that causes the characteristic plaques seen in the brains of Alzheimer’s patients.
UT Southwestern molecular biologist and Alzheimer’s expert Dr. Joachim Herz, lead author of the study, which was published in the November issue of eLife said the goal of his team is to prevent the disease from ever manifesting. Late-onset Alzheimer’s generally is diagnosed about age 65 and is the most common cause of dementia in the elderly. “If we can negate the ApoE4 process early, we may be able to prevent late-onset Alzheimer’s altogether for many people so that they will never get sick,” Dr. Herz said.
ApoE4 has been shown to suppress and trap synaptic receptors within intracellular vesicles. However, how the ApoE4 gets trapped has remained a mystery until now. According to Dr. Herz, ApoE4 is the root cause of a “traffic jam” inside the cells that take up ApoE4 and this is associated with reduced recycling of intracellular endosomal transport vesicles. UTSW researchers found that lowering the pH of these endosomes, i.e., by making them more acidic, cleared the traffic jam: The scientists were able to completely reverse the ApoE4-induced recycling block in mice through pharmacological and genetic inhibition of the NHE6 protein, which acts to make the endosomal vesicles less acidic.
These findings suggest a novel potential therapeutic approach for the prevention of late-onset Alzheimer’s disease, Dr. Herz said. The vesicle traffic jam due to the selective loss of solubility of ApoE4 likely is the earliest mechanism at which the protein negatively affects nerve cells, Dr. Herz said.
Most Alzheimer’s research has focused on halting the formation of amyloid and tau protein aggregates once they exist in the brain and degeneration has already begun. “Our approach in this study was to stop the overall degeneration process earlier; that is, before the formation of these aggregates,” Dr. Herz said.
The next step is to develop tailor-made, small molecule inhibitors that can enter the brain efficiently and selectively block NHE6, he added.
“The beauty of NHE inhibitors is that these are small molecules that can be produced inexpensively and thus made widely available, in contrast to the more elaborate antibody-based therapies that are currently being evaluated in clinical trials. A simple pill could someday neutralize the risk of late-onset Alzheimer’s disease just as readily available statins are able to reduce the risk of cardiovascular disease,” Dr. Herz said.
The Latest on: Late-onset Alzheimer’s
via Google News
The Latest on: Late-onset Alzheimer’s
- Alzheimer’s disease polygenic risk score as a predictor of conversion from mild-cognitive impairment on May 24, 2019 at 2:34 am
A cohort of 122 individuals diagnosed with MCI and followed up for a 36-month period for conversion to late-onset Alzheimer’s disease (LOAD) were genotyped on the NeuroChip array along with ... […]
- Dementia warning: Common sign of Alzheimer’s you may be missing - and it happens at home on May 21, 2019 at 1:44 pm
“For most people with Alzheimer’s—those who have the late-onset variety—symptoms first appear in their mid-60s. “In mild Alzheimer’s disease, a person may seem to be healthy but has more and more ... […]
- Alzheimer's could be spotted up to 34 YEARS before symptoms begin on May 15, 2019 at 4:42 am
More than five million Americans have Alzheimer’s. It is unknown what causes Alzheimer's. Those who have the APOE gene are more likely to develop late-onset Alzheimer's. Mild Alzheimer's (early-stage) ... […]
- Retrotope Announces RT001 Clinical Data Presentation at the 2019 American Academy of Neurology (AAN) Annual Meeting on May 6, 2019 at 9:57 am
Late-onset Tay-Sachs disease (LOTS ... are being studied as disease-modifying therapies for many intractable diseases, such as Parkinson’s, Alzheimer’s, mitochondrial myopathies, and retinopathies. ... […]
- Alzheimer's Disease Diagnostic Market Expects to Worth Over $12 Bn by Renowned Players and Business Insights to 2022 on April 16, 2019 at 11:07 am
by Type (Early-onset Alzheimer's, Late-onset Alzheimer's, Familial Alzheimer's disease), by Diagnostic test (Genetic testing, Neurological exam, Mini-mental state exam (MMSE), Brain imaging and ... […]
- Blood test shows promise in predicting presymptomatic disease progression in people at risk of familial Alzheimer’s on April 3, 2019 at 6:45 am
It is unknown if NfL in blood might help predict onset of the more common, late-onset form of Alzheimer’s dementia, as well as other neurodegenerative diseases. Specialized brain scans and lumbar ... […]
- late-onset Alzheimer’s disease on March 12, 2019 at 2:00 am
Predicting whether someone will get Alzheimer’s disease (AD) late in life, and how to use that information for prevention, has been an intense focus of biomedical research. The goal of this work is to ... […]
- Scientists find 5 new genes that make people more vulnerable to Alzheimer's on March 4, 2019 at 6:20 am
And they discovered a formerly unknown common feature between early-onset and late-onset Alzheimer disease – how certain proteins called amyloid precursor proteins are broken down. The latter finding ... […]
- Pooling of data reveals five new genes that boost Alzheimer’s risk on March 4, 2019 at 4:15 am
The International Genomic Alzheimer’s Project (IGAP), composed of four consortia ... conducted an analysis of both rare and common gene variants in patients with late onset Alzheimer’s disease. ... […]
- Five new Alzheimer's disease risk genes found in NIH-funded study on March 1, 2019 at 7:17 am
RELATED Alzheimer's breakthrough may come from bone marrow experiment with mice The researchers analyzed common and unique gene variants in more than 94,000 people with late-onset Alzheimer's, ... […]
via Bing News